ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma
Saved in:
Main Authors: | Priya Tripathi, Shally Awasthi, Peisong Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/572025 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
by: Sooyeon Oh, et al.
Published: (2025-01-01) -
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
by: Marcia L. Moss, et al.
Published: (2017-01-01) -
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
by: Haotian Ma, et al.
Published: (2024-11-01) -
Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies
by: Sheryl Y. T. Lim, et al.
Published: (2025-01-01) -
Adams's Outline of Orthopaedics /
by: Hamblen, David L.
Published: (2010)